Edwards Valve Comparable To Traditional Surgery, FDA Says

Law360, New York (June 11, 2012, 7:05 PM EDT) -- Patients who received a new, less invasive type of heart valve from Edwards Lifesciences Corp. survived at about the same rate as those undergoing traditional open-heart surgery, but strokes were significantly more common, the U.S. Food and Drug Administration reported Monday.

The announcement comes in advance of a Wednesday hearing where an FDA advisory panel will consider recommending approval of the device in patients for whom traditional surgery is extremely risky, extending it from patients for whom open-heart procedures are not possible.

Edwards won agency backing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.